4.5 Article

Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

Kevin Kalinsky et al.

Summary: The study showed that among premenopausal women with hormone-receptor-positive, HER2-negative breast cancer and one to three positive lymph nodes with a recurrence score of 25 or lower, the addition of chemotherapy to endocrine therapy led to longer invasive disease-free survival and distant relapse-free survival compared to endocrine therapy alone. However, postmenopausal women with similar characteristics did not benefit from adjuvant chemotherapy in terms of invasive disease-free survival.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Oncology

Discordance in Oncotype DX Breast Recurrence Score(R) Results for Bilateral Breast Cancer

Joshua A. Bloom et al.

Summary: This study demonstrates that a clinically significant rate of discordance in Oncotype DX results among patients with bilateral breast cancer may impact discussions regarding chemotherapy treatment.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Surgery

Multifocal and multicentric breast cancer, is it time to think again?

Y. A. Masannat et al.

ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND (2020)

Article Medical Laboratory Technology

Evaluation of Biomarkers in Multiple Ipsilateral Synchronous Invasive Breast Carcinomas

Pooja Navale et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)

Article Oncology

National trends of synchronous bilateral breast cancer incidence in the United States

Takehiko Sakai et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Oncology

Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer

Linda S. Lindstrom et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Oncology

Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer

Linda S. Lindstrom et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Oncology

Breast Cancer-Major Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual

Armando E. Giuliano et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

Article Oncology

Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer

Maria Karsten et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

Article Medicine, General & Internal

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

J. A. Sparano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Oncology

Oncotype Dx Results in Multiple Primary Breast Cancers

Michael J. Toole et al.

BREAST CANCER-BASIC AND CLINICAL RESEARCH (2014)

Review Oncology

Breast cancer intra-tumor heterogeneity

Luciano G. Martelotto et al.

BREAST CANCER RESEARCH (2014)

Article Oncology

Heterogeneity of breast cancer: etiology and clinical relevance

Vanessa Almendro et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2011)

Review Oncology

Multiple synchronous (multifocal and multicentric) breast cancer: Clinical implications

Sofiane Bendifallah et al.

SURGICAL ONCOLOGY-OXFORD (2010)

Article Radiology, Nuclear Medicine & Medical Imaging

Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound

LS Wilkinson et al.

CLINICAL RADIOLOGY (2005)

Article Medicine, General & Internal

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

S Paik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)